文章摘要
闫淑鑫,张淑静,袁慧敏,孙逸卓,骈 雪,孙 燕,汤 阳.INTU-siRNA质粒的构建及在人甲状腺Nthy-ori-3-1细胞中的筛选[J].,2024,(6):1001-1006
INTU-siRNA质粒的构建及在人甲状腺Nthy-ori-3-1细胞中的筛选
Construction of the INTU-siRNA Plasmid and Screening in Human Thyroid Nthy-ori-3-1 Cells
投稿时间:2023-11-23  修订日期:2023-12-18
DOI:10.13241/j.cnki.pmb.2024.06.001
中文关键词: INTU-siRNA质粒  人甲状腺Nthy-ori-3-1细胞  Graves病
英文关键词: INTU-siRNA plasmid  Human thyroid Nthy-ori-3-1 cells  Graves' disease
基金项目:国家自然科学基金项目(82004337);中央高校基本科研业务费自主选题(2020-JYB-XJSJJ-002)
作者单位E-mail
闫淑鑫 北京中医药大学中医学院 北京 102488 yanshuxin528@bucm.edu.cn 
张淑静 北京中医药大学中医学院 北京 102488  
袁慧敏 北京中医药大学中医学院 北京 102488  
孙逸卓 北京中医药大学中医学院 北京 102488  
骈 雪 北京中医药大学中医学院 北京 102488  
孙 燕 北京中医药大学中医学院 北京 102488  
汤 阳 北京中医药大学中医学院 北京 102488  
摘要点击次数: 388
全文下载次数: 222
中文摘要:
      摘要 目的:构建人源靶向特异INTU-siRNA质粒,转染人源性甲状腺Nthy-ori-3-1细胞以构建INTU基因沉默的Nthy-ori-3-1细胞模型,为探索Graves病的发病机制提供合适的细胞模型。方法:构建四对人源INTU序列(编号分别为INTU-29、INTU-31、INTU-33、INTU-35)siRNA质粒和空载体质粒,将空载体和四对INTU-siRNA质粒分别转染Nthy-ori-3-1细胞培养24 h,通过倒置荧光显微镜观察质粒转染细胞后的荧光表达,使用多功能酶标仪检测荧光强度,通过荧光定量PCR法验证INTU基因的沉默效率,通过蛋白质免疫印迹法验证各组细胞内INTU蛋白的表达水平,筛选沉默INTU基因效率最佳的质粒。结果:空载体和INTU-siRNA质粒转染入Nthy-ori-3-1细胞24 h后,倒置荧光显微镜和荧光酶标仪检测结果显示空载体和四组INTU-siRNA组呈现绿色的荧光表达,与正常组相比,空载体与四组INTU-siRNA组的荧光强度均显著高于正常组(P<0.01),提示质粒均转染成功。荧光定量PCR结果显示,与正常组和空载体组相比,四组INTU-siRNA组的INTU基因mRNA相对表达量均显著降低(P<0.01),其中INTU-35组表达降低最显著,INTU的mRNA表达降低了61.02 %。蛋白质免疫印迹法结果显示,与正常组和空载体相比,INTU-29组和INTU-31组并无显著降低,INTU-33和INTU-35组较正常组和空载体组明显下降(P<0.05,P<0.01),其中INTU-35组最佳,INTU的蛋白表达降低了44.54 %。以上结果提示INTU-35组沉默INTU基因效果最佳。结论:本研究成功构建INTU-siRNA质粒,并将该质粒成功转染人源甲状腺Nthy-ori-3-1的细胞模型。INTU-siRNA甲状腺细胞模型的构建,为进一步探索Graves病的发病机制奠定了实验基础。
英文摘要:
      ABSTRACT Objective: The target-specific INTU-siRNA plasmids were constructed and transfected into Human thyroid Nthy-ori-3-1 cells to establish the Nthy-ori-3-1 cell model of silenced-INTU. This model provides a suitable cell model for exploring the pathogenesis of Graves' disease. Methods: Four pairs of human INTU sequences (numbered INTU-29, INTU-31, INTU-33, INTU-35) siRNA plasmids and an empty vector plasmid were constructed and individually transfected into Nthy-ori-3-1 cells, which were then cultured for 24 hours. The fluorescence expression of each group was observed using a Fluorescent Inverted Microscope, and the fluorescence intensity was detected by a Multi-function Measuring Instrument. The silencing efficiency of the INTU gene was determined by fluorescence quantitative PCR and Western blotting. Finally, the most effective silenced-INTU plasmid was identified through screening. Results: After the empty vector and the four INTU-siRNA plasmids were transfected into Nthy-ori-3-1 cells for 24 hours, the results of Fluorescent Inverted Microscope and Multi-function Measuring Instrument indicated that the four INTU-siRNA groups showed green fluorescence expression, and their fluorescence intensity was significantly higher than the normal group (P<0.01), suggesting that the plasmids were successfully transfected. The results of fluorescence quantitative PCR demonstrated that the relative mRNA expression of the INTU gene in four INTU-siRNA groups was significantly reduced compared with the normal group and the empty vector group (P<0.01), with the most significant reduction of the INTU-35 group decreased by 61.02 %. The results of Western blotting showed that compared to the normal group and the empty vector group, the INTU-29 and the INTU-31 group did not exhibit a significant decrease, while the INTU-33 and INTU-35 groups showed a remarkable decline(P<0.05, P<0.01), with the protein expression of the INTU-35 group reduced by 44.54 %. These results suggest that the INTU-35 group achieved the most effective silencing of the INTU gene. Conclusion: In this study, the INTU-siRNA plasmids were successfully constructed and transfected into human thyroid Nthy-ori-3-1 cells. The construction of the INTU-siRNA thyroid cell model lays the experimental foundation for further exploring the pathogenesis of Graves' disease.
查看全文   查看/发表评论  下载PDF阅读器
关闭